" /> Ziftomenib - CISMeF





Preferred Label : Ziftomenib;

NCIt synonyms : Menin-MLL Inhibitor KO-539; Menin-Mixed Lineage Leukemia Protein-Protein Interaction Inhibitor KO 539; Menin-KMT2A Inhibitor KO 539; Menin-MLL Interaction Inhibitor KO 539;

NCIt definition : An orally bioavailable inhibitor of the menin-mixed lineage leukemia (MLL; myeloid/lymphoid leukemia; KMT2A) fusion protein, with potential antineoplastic activity. Upon oral administration, ziftomenib prevents the interaction between the two proteins menin and MLL, and thus the formation of the menin-MLL complex. This reduces the expression of downstream target genes and results in an inhibition of the proliferation of MLL-rearranged leukemic cells. The menin-MLL complex plays a key role in the survival, growth and proliferation of certain kinds of leukemia cells.;

UNII : 4MOD1F4ENC;

CAS number : 2134675-36-6;

Molecule name : KO 539; KO-539;

NCI Metathesaurus CUI : CL977514;

Détails


Vous pouvez consulter :


Nous contacter.
31/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.